Point72 Hong Kong’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$107K Buy
+13,524
New +$96.2K ﹤0.01% 349
2025
Q2
Sell
-4,607
Closed -$37.6K 545
2025
Q1
$37.6K Buy
+4,607
New +$42.6K ﹤0.01% 385
2022
Q4
Sell
-13,601
Closed -$142K 666
2022
Q3
$142K Buy
+13,601
New +$152K 0.01% 1138
2022
Q2
Sell
-12,685
Closed -$120K 2082
2022
Q1
$120K Buy
12,685
+1,646
+15% +$15.4K ﹤0.01% 1104
2021
Q4
$128K Sell
11,039
-6,800
-38% -$75.8K ﹤0.01% 1115
2021
Q3
$170K Buy
17,839
+12,094
+211% +$124K 0.01% 1214
2021
Q2
$55K Buy
+5,745
New +$56.1K ﹤0.01% 1450
2021
Q1
Sell
-243
Closed -$6K 1942
2020
Q4
$6K Buy
+243
New +$4.97K ﹤0.01% 1581
2020
Q2
Sell
-1,370
Closed -$13K 1235
2020
Q1
$13K Buy
1,370
+1,325
+2,944% +$12.6K 0.01% 631
2019
Q4
$0 Sell
45
-1,529
-97% -$14K ﹤0.01% 1250
2019
Q3
$13K Sell
1,574
-2,332
-60% -$25.3K ﹤0.01% 736
2019
Q2
$49K Buy
+3,906
New +$49.6K 0.01% 637
2019
Q1
Sell
-59
Closed -$1K 1108
2018
Q4
$1K Sell
59
-2,980
-98% -$32.8K ﹤0.01% 790
2018
Q3
$37K Buy
3,039
+2,788
+1,111% +$39K 0.01% 508
2018
Q2
$4K Buy
+251
New +$3.79K ﹤0.01% 724

Other funds holding FOLD

Point72 Hong Kong's FOLD Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Amicus Therapeutics (FOLD) in Q3 2025: 13,524 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in FOLD as recently as Q1 2025.

Point72 Hong Kong first reported a position in FOLD in Q2 2018 and has held it in 15 quarters since. The position peaked at $170K in Q3 2021. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Point72 Hong Kong held 13,524 shares of Amicus Therapeutics worth $107K as of Q3 2025.
  • Amicus Therapeutics was a new Point72 Hong Kong position in Q3 2025.
  • Amicus Therapeutics made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #349 holding.
  • Point72 Hong Kong first reported a position in Amicus Therapeutics in Q2 2018 and has held it in 15 quarters since.
  • Point72 Hong Kong's Amicus Therapeutics position peaked at $170K in Q3 2021.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.